US drug regulator issues warning letter to Sun Pharma on CGMP
Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.
Consumption of fast food may lead to nonalcoholic fatty liver disease, a life-threatening condition, according to researchers from the Keck School of Medicine.
Global growth may decelerate sharply in 2023 to its third weakest pace in nearly three decades, according to World Bank’s Global Economic Prospects.
A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor.
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.
A global shortage of healthcare workers may rise to 10 million by 2030, affecting access to care, increasing inequities and treatment of mental.
A new artificial intelligence-driven model can analyse magnetic resonance imaging of brain scans to accurately capture cognitive decline linked to neurodegenerative diseases such.
US scientists have combined two technologies to show the effect of glucose in polycystic kidney disorder, a life-threatening genetic disorder, according to a.
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com